Multinational Australian labs group Sonic is acquiring regional German labs group Medical Laboratories Duesseldorf (MLD), in its second acquisition in the sector in the space of one month.
German health minister Karl Lauterbach’s controversial hospital reforms have hit another bump in the road, with a new 144 page legal report stating the proposals are outside of the federal government's jurisdiction - and against the constitution.
The nursing home industry in Germany has been rocked by a spate of bankruptcies in recent months. As another operator bites the dust, it has left many wondering - are more to come? HBI speaks to two market experts to decipher whether the ‘once is a mistake, twice is a coincidence, three times is a pattern’ adage holds any water.
Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion.
German nursing homes are struggling to attract staff in a competitive workplace, as paperwork and regulations are getting in the way. Two market experts tell HBI bureaucracy is stifling growth at a time when it is vital a pragmatic view is taken of the workforce.
It has been almost two years since listed Germany-based healthcare property specialist Vonovia acquired its former rival Deutsche Wohnen. We speak to three Germany-based experts to find about more about the ongoing sale of its £1.3bn property portfolio.
Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.
Multinational Australian labs giant Sonic is buying Diagnosticum, a medium-sized German labs chain which operates 15 laboratories and employs 25 pathologists, for €190m.
Abu Dhabi sovereign wealth fund Mubadala Investment Co is considering the acquisition of $2.5bn Swedish pan-European dialysis group Diaverum, according to reports.
With Covid hopefully on the wane, the firm foothold digital health established in many markets is looking a little less stable. What next for groups like Swedish telehealth firm Kry? HBI speaks to two experts and Kry itself to find out why telehealth is getting physical.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
